Biologics CDMO Secondary Packaging Market Companies and their Innovations
The biologics CDMO secondary packaging market size reached US$ 2.38 billion in 2024 and is projected to hit around US$ 5.50 billion by 2034, expanding at a CAGR of 8.75% during the forecast period from 2024 to 2034.
Biologics CDMO Secondary Packaging Market Top Companies
- Cavanna Packaging Group
- Loesch Verpackungstechnik GmbH
- Theegarten-Pactec
- Bradman Lake Group
- FUJI MACHINERY CO.LTD.
- Tecno Pack Spa
Latest Announcements by Market Leaders
- In March 2024, SMC Ltd. Vice President and General Manager, Uri Baruch expressed “There are notable developments in the injectables market – the growth of more complex biologics and the increased interest in delivering large volumes of API. We believe our ability to deliver, at speed, fill volumes from 1ml to 50ml is an unmet need and is already attracting significant attention from our clients and partners."
Recent Developments
- In March 2024, SMC Ltd., announced the expansion of Sterile Fill Finish Capabilities in North Carolina. It helps SMC to deliver a wider portfolio of services to its pharma clients including lab-to-market development, analytical services, device manufacture, fill/finish, final assembly, and secondary packaging.
- In March 2024, Hovione collaborated with GEA to announce the launch of ConsiGma CDC flex and the installation of a new lab-scale R&D Continuous Tableting rig in Hovione´s facilities in Portugal.
